The most common cause of a stroke is a blood clot that blocks a blood vessel in the brain (ischaemic stroke). The clot prevents brain cells from receiving an adequate supply of oxygen and nutrients, causing them to die. To prevent permanent damage or, in the worst case, the death of the person affected, a thrombus must be removed as quickly as possible. Acute treatment currently consists of two procedures: thrombolysis (lysis therapy) and thrombectomy. In the former, stroke patients are administered a substance designed to dissolve the blood clot; in the latter, the clot is removed mechanically using so-called catheters. In most cases, patients undergoing thrombectomy first receive lysis therapy; however, this carries an increased risk of bleeding. It is not yet clear whether the combined approach yields better results than thrombectomy alone – recent international studies have reached conflicting conclusions on this point. The results of a new international study have now been presented. This study clearly shows that thrombectomy alone yields poorer results than the combined approach. For the study, 408 patients with an acute stroke were recruited between 2017 and 2021 at 48 different stroke centres in Europe and Canada. Half of the study participants received thrombectomy alone, whilst the other half received combination therapy. With combination therapy, blood flow was restored in 96 per cent of those affected, compared with just 91 per cent with monotherapy. The proportion of patients who were able to live independently three months after their stroke was 65 per cent among those receiving combination therapy, compared with 57 per cent among study participants who underwent thrombectomy alone. The feared risk of cerebral haemorrhage was not significantly higher with combination therapy than with thrombectomy alone (3 per cent vs. 2 per cent). As a next step, the researchers plan to test a treatment approach in which small doses of a thrombolytic drug are administered following a thrombectomy. This may further reduce the degree of impairment following a stroke. Reference: University of Bern Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial, Lancet 2022; https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)00537-2/fulltext?s=08
Stroke: combination therapy is better than monotherapy